Neutralizing Antibody Market Forecast 2025–2034: Where Businesses Should Invest Next

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Neutralizing Antibody Market Between 2025 And 2029?

The neutralizing antibody market has experienced substantial expansion in recent years. Its valuation is forecast to climb from $230.25 billion in 2024 to $257.81 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.0%. This market’s historical growth can be attributed to several factors, including an increase in biologics approvals, enhanced funding for antibody research, the rising occurrence of chronic viral infections, heightened awareness regarding immunotherapy, and growing healthcare spending.

The neutralizing antibody market size is anticipated to experience significant expansion in the upcoming years. It is predicted to surge to $401.16 billion by 2029, achieving a compound annual growth rate (CAGR) of 11.7%. This projected growth can be attributed to the increasing prevalence of emerging infectious diseases, a rise in autoimmune disorders, the expanding pipeline of antibody-based therapies, the escalating demand for precision medicine, and the growing need for targeted therapies. Noteworthy trends for the forecast period include a transition towards bispecific and multispecific antibodies, the integration of artificial intelligence (AI) in antibody discovery, advancements in the development of antibody-drug conjugates, an increasing utilization of plant-based antibody production, and a surge in personalized immunotherapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24620&type=smp

Which Drivers Are Impacting The Neutralizing Antibody Market?

An increase in infectious diseases is anticipated to drive the future expansion of the neutralizing antibody market. These diseases are defined as ailments resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals either directly or indirectly. The growing incidence of infectious diseases stems from enhanced travel, enabling swift global dissemination of pathogens. Neutralizing antibodies improve infectious disease treatment by precisely targeting and inhibiting pathogens, thereby effectively preventing disease advancement. They contribute to better patient outcomes by offering accurate and prompt immune defense. For example, data from February 2024, released by the UK Health Security Agency, a government body in the UK, indicated that tuberculosis (a contagious bacterial infection predominantly impacting the lungs) cases in England climbed to 4,850 in 2023, marking a 10.7% rise from 4,380 cases in 2022. Consequently, the increased prevalence of infectious diseases is stimulating the expansion of the neutralizing antibody market.

What Are The Major Segment Types Covered In The Neutralizing Antibody Market?

The neutralizing antibody market covered in this report is segmented –

1) By Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies

2) By Target Virus: SARS-CoV-2 (COVID-19), Human Immunodeficiency Viruses (HIV), Influenza, Ebola, Zika, Hepatitis C, Other Target Viruses

3) By Distribution Channel: Direct Sales To End-Users, Distributors, Online Retail, Other Distribution Channels

4) By Application: Therapeutics, Diagnostics, Research And Development

5) By End User: Hospitals And Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Monoclonal Antibodies: Fully Human Monoclonal Antibodies, Humanized Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Murine Monoclonal Antibodies

2) By Polyclonal Antibodies: Animal-Derived Polyclonal Antibodies, Recombinant Polyclonal Antibodies, Human Polyclonal Antibody Preparations

How Are Emerging Market Trends Shaping The Neutralizing Antibody Industry Landscape?

Leading companies in the neutralizing antibody market are prioritizing the creation of advanced therapies, such as targeted treatments, to combat infectious diseases by precisely neutralizing viruses and preventing their entry into human cells. Targeted therapies refer to treatments that specifically address molecular markers or pathways critical for the growth and survival of disease-causing cells, including cancer or viruses. For instance, in February 2022, Eli Lilly and Company, a US-based pharmaceutical firm, was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for Bebtelovimab, a neutralizing monoclonal antibody therapy for COVID-19. Bebtelovimab is intended for the treatment of mild to moderate COVID-19 in patients who are at a high risk of developing severe disease, including hospitalization or death. This authorization allows for rapid treatment as new viral variants emerge, assisting in efforts to decrease disease severity and enhance patient outcomes.

Which Key Players Are Driving Competition In The Neutralizing Antibody Market?

Major companies operating in the neutralizing antibody market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AstraZeneca PLC, Sanofi SA, GlaxoSmithKline plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., GeNext Genomics, Celltrion Healthcare Co. Ltd, BeiGene Ltd, AbCellera Biologics Inc., BMC Pharmacology and Toxicology, Anthos Therapeutics, Immunome Inc., Sorrento Therapeutics Inc., Tonix Pharmaceuticals, Abwiz Bio, AXIM Biotechnologies.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/neutralizing-antibody-global-market-report

Which Regional Markets Are Contributing Most To The Neutralizing Antibody Industry Expansion?

North America was the largest region in the neutralizing antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neutralizing antibody market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Neutralizing Antibody Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24620&type=smp

Browse Through More Reports Similar to the Global Neutralizing Antibody Market 2025, By The Business Research Company

Immune Health Supplements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Immunoglobulins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Antibody Discovery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795